1 |
Yang Y, Liang L, Zhai Z, et al. Pulmonary embolism incidence and fatality trends in chinese hospitals from 1997 to 2008: a multicenter registration study[J]. PLoS One, 2011, 6(11): e26861.
|
2 |
程显声. 进一步提高肺动脉栓塞诊断与处理水平[J]. 中华结核和呼吸杂志,2000, 23(9): 517-518.
|
3 |
Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy[J]. Chest, 1995, 108(4): 978-981.
|
4 |
Hull RD. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings[J]. Thromb Haemost, 2008, 99(3): 502-510.
|
5 |
Almahameed A, Carman TL. Outpatient management of stable acute pulmonary embolism: proposed accelerated pathway for risk stratification[J]. Am J Med, 2007, 120(10 Suppl 2): S18-S25.
|
6 |
Becattini C, Agnelli G, Germini F, et al. Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis[J]. Eur Respir J, 2014, 43(6): 1678-1690.
|
7 |
Sanchez O, Trinquart L, Planquette B, et al. Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism[J]. Eur Respir J, 2013, 42(3): 681-688.
|
8 |
中华医学会心血管病学分会肺血管病学组. 中国急性肺栓塞诊断与治疗指南. 2015.
|
9 |
Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2014, 35(43): 3033-3069, 3069a-3069k.
|
10 |
李冬云,聂秀红,杨强. APACHEⅡ和SAPSⅡ评估呼吸危重症患者预后的研究[J]. 临床肺科杂志,15(10): 1416-1418.
|
11 |
Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism[J]. Arch Intern Med, 2010, 170(15): 1383-1389.
|
12 |
Ozsu S, Ozlu T, Senturk A, et al. Combination and comparison of two models in prognosis of pulmonary embolism: results from TUrkey Pulmonary Embolism Group (TUPEG) study[J]. Thromb Res, 2014, 133(6): 1006-1010.
|
13 |
Zhou XY, Ben SQ, Chen HL, et al. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis[J]. Respir Res, 2012, 13: 111.
|
14 |
Stamm JA. Risk stratification for acute pulmonary embolism[J]. Crit Care Clin, 2012, 28(2): 301-321.
|
15 |
Lankeit M, Gomez V, Wagner C, et al. A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism[J]. Chest, 2012, 141(4): 916-922.
|
16 |
Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis[J]. Am J Respir Crit Care Med, 2008, 178(4): 425-430.
|
17 |
王彩玲. 早期急性肺栓塞患者血浆标志物变化的研究[J]. 河北医药,2012, 34(1): 80-81.
|
18 |
Agterof MJ, Schutgens RE, Snijder RJ, et al. Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level[J]. J Thromb Haemost,2010 Jun, 8(6): 1235-1241.
|
19 |
Vuilleumier N, Limacher A, Mean M, et al. Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism[J]. J Intern Med, 2015, 277(6): 707-716.
|
20 |
陈恒. PESI联合BNP cTnI在急性肺栓塞诊断及危险分层中的价值[J]. 浙江临床医学,2015, 17(11): 1887-1889.
|